Skip to main content
. 2018 Oct 1;41(12):2480–2486. doi: 10.2337/dc18-0861

Table 1.

Baseline characteristics of study participants, overall and by subgroup, i.e., participants with ≥1 risk allele versus none at the TCF7L2 locus

Characteristic All subjects, N = 244 ≥1 risk allele, N = 135 No risk alleles, N = 109 P value
Sex 0.93
 Female 128 (52.5) 70 (51.9) 58 (53.2)
 Male 116 (47.5) 65 (48.1) 51 (46.8)
Age at confirmed single Ab+ (years) 0.50
 Median 12.8 13.45 12.5
 Range 1.22–45.9 1.22–45.9 1.3–45.7
Islet Ab+ type 0.71
 GAD65 158 (64.8) 87 (64.4) 71 (65.1)
 IA-2 17 (6.7) 11 (8.1) 6 (5.5)
 mIAA 69 (28.3) 37 (27.4) 32 (29.4)
Race 0.46
 White 220 (96.5) 119 (96) 101 (97.1)
 Black/African American 3 (1.3) 2 (1.6) 1 (1.0)
 Asian 1 (0.4) 1 (0.8) 0 (0.0)
 Multiracial 4 (1.8) 2 (1.6) 2 (1.9)
 Unknown/missing 16 1 5
Ethnicity 0.45
 Hispanic/Latino 23 (9.7) 12 (9.0) 11 (10.4)
 Non-Hispanic/Latino 214 (90.3) 121 (91.0) 93 (89.4)
 Unknown/missing 7 2 5
Fasting C-peptide (ng/mL) 0.71
 Median 1.52 1.56 1.49
 Range 0.38–7.3 0.38–5.13 0.43–7.3
 Missing 2 2 0
C-peptide AUC 0.10
 Median 649.9 628.5 681.8
 Range 197.8–3,089.4 197.8–1,652.3 242.4–3,089.4
 Missing 12 9 3
OGTT status 0.44
 Normal 196 (81.7) 105 (79.5) 91 (84.6)
 Abnormal 44 (18.3) 27 (20.5) 17 (15.7)
 Missing time point 4 3 1
HLA DR3 and DR4 0.21
 No 217 (92.3) 117 (90.0) 100 (95.2)
 Yes 18 (7.7) 13 (10.0) 5 (4.8)
 Missing 9 5 4
HLA DR3 and/or DR4 0.999
 No 74 (31.5) 41 (31.5) 33 (31.4)
 Yes 161 (68.5) 89 (68.5) 72 (68.6)
 Missing 9 5 4
BMI category 0.033
 Normal 131 (58.2) 78 (61.9) 53 (53.5)
 Overweight 48 (21.3) 18 (14.3) 28 (28.3)
 Obese 46 (20.4) 30 (23.8) 18 (18.2)
 Missing 19 9 10

Data are n or n (%) unless otherwise indicated. P values are given for the comparison of the characteristic between groups. Continuous measures were compared using Wilcoxon rank sum test. Categorical variables were compared using χ2 tests (or Fisher exact tests if cell sizes too small). Ab+, autoantibody positivity; AUC, area under the curve; OGTT, oral glucose tolerance test.